CAS 2070015-14-2

Atovaquone-d4

CAS : 2070015-14-2

Formule : C₂₂H₁₅D₄ClO₃

Couleur et forme : Yellow Solid

Masse moléculaire : 370.87

Ref: 4Z-A-271

Atovaquone-d4

CAS : 2070015-14-2

Atovaquone D4 is a deuterium-labeled drug for treating malaria, pneumonia, and toxoplasmosis.

Formule : C₂₂H₁₉ClO₃

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 370.86

Ref: TM-T19198

Atovaquone-d4

CAS : 2070015-14-2

Atovaquone-d4 is an analog of atovaquone, a medication used to treat and prevent malaria. It is also being studied as a potential anticancer agent. Atovaquone-d4 works by inhibiting kinases, which are enzymes involved in cell signaling pathways that can contribute to cancer growth and survival. In Chinese hamster ovary cells, atovaquone-d4 has been shown to inhibit the activity of several different kinases, including those involved in regulating cell cycle progression and promoting cell survival. This inhibitor has also been found to induce apoptosis, or programmed cell death, in human cancer cells. Atovaquone-d4 is currently being investigated for its potential medicinal properties as an anticancer agent and may hold promise for future cancer treatments.

Formule : C₂₂H₁₉ClO₃

Degré de pureté : Min. 95%

Masse moléculaire : 370.9 g/mol

Ref: 3D-VHD01514